Lilly’s New Weight Loss Pill Shows 12% Body Fat Reduction

An experimental GLP-1 pill from Eli Lilly is making serious waves in the obesity treatment world, and for good reason. In its first Phase 3 trial, the once-daily oral medication, orforglipron, helped people lose an average of 12.4% of their body weight over 72 weeks. That’s about 27 pounds down, with no injections involved and […]